Accomplished Director and Executive – CEO – Managing Director, demonstrating profound experience directing overall business operations. Leading high profile organizations in Europe, North America and Asia Pacific in corporate turn-around situations, start-up situations and “extreme” business conditions by meeting and exceeding set goals. Communicator with a distinctive ability to build strong relationships with stakeholders, key customers and senior executives to achieve challenging business goals.

From 2005, Francesca has been a Managing Director of META Ventures (MV), the financial company of META Group managing public-private co-investment risk capital funds in Italy, Poland and Slovenia. She has a deep experience knowledge on key features and regulation of EU financial instruments, having worked for the European Commission and other important international donors (EIB).

Accomplished Director and Research Leader with deep expertise in biomaterials, regenerative medicine, and advanced ceramic technologies. As Director of Research at ISSMC-CNR, she has led major European and international projects, translating cutting-edge science into innovative healthcare solutions. Tampieri combines scientific excellence with extensive experience in technology transfer, entrepreneurship, and cross-sector collaboration, fostering partnerships that advance biomedical innovation and global impact.

Strategic investment professional and corporate advisor with extensive experience in venture capital, portfolio management, and governance. Senior Investment Associate at Alchimia Investments, Riccio supports early-stage and growth companies across Europe and the US, providing strategic, financial, and operational guidance. With a track record in board-level decision-making and fostering value creation, she bridges management teams, investors, and stakeholders to drive sustainable growth and innovation.

Renowned scientist and innovation leader in nanomedicine and regenerative therapies. Full Professor at San Raffaele University and Founder of the Human Longevity Program at IRCCS San Raffaele, he is recognized globally for pioneering research in tissue repair, immune modulation, and translational biomedical technologies. Tasciotti has directed major international research centers, secured multi-million-dollar funding, and guided interdisciplinary teams to deliver clinical and commercial solutions, bridging science, industry, and venture innovation.